| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc. (DYN) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 28 sells. DYN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 5.28M | $110.10M | - | |
| Dir | 1.16M | $24.19M | - | |
| CEO | 368.2K | $7.68M | -2,683 | |
| Other | 169.2K | $3.53M | -887 | |
| Other | 154.2K | $3.22M | -145 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | McNeill Jonathan55 | Chief Business Officer | Sell | 2,774 | $28.27 | $78,419.85 | -1.0% | +52.6% | -58.9% | |
| Mar 12, 2024 | Farwell Wildon55 | Chief Medical Officer | Sell | 2,615 | $25.65 | $67,081.90 | -0.9% | +16.2% | -54.4% | |
| Mar 11, 2024 | Beskrovnaya Oxana58 | Chief Scientific Officer | Sell | 2,081 | $25.70 | $53,481.70 | -1.3% | +23.3% | -52.9% | |
| Mar 11, 2024 | Scalzo Richard William58 | SVP, Head Of Finance &Admin. | Sale+OE | 88,924 | $26.19 | $2,329,006.68 | -11.8% | +23.3% | -52.9% | |
| Mar 11, 2024 | Brumm Joshua T54 | CEO &President | Sale+OE | 429,730 | $25.89 | $11,125,776.16 | -9.6% | +23.3% | -52.9% | |
| Mar 11, 2024 | McNeill Jonathan55 | Chief Business Officer | Sale+OE | 109,601 | $26.11 | $2,861,373.09 | -12.6% | +23.3% | -52.9% | |
| Mar 11, 2024 | High Susanna Gatti66 | Chief Operating Officer | Sell | 29,491 | $26.59 | $784,247.99 | -5.8% | +23.3% | -52.9% | |
| Mar 7, 2024 | Scalzo Richard William58 | SVP, Head Of Finance &Admin. | Sell | 2,273 | $25.85 | $58,757.05 | -1.8% | +24.4% | -53.1% | |
| Mar 7, 2024 | Brumm Joshua T54 | CEO &President | Sell | 9,086 | $25.85 | $234,873.10 | -1.6% | +24.4% | -53.1% | |
| Mar 7, 2024 | Beskrovnaya Oxana58 | Chief Scientific Officer | Sell | 2,373 | $25.85 | $61,342.05 | -1.5% | +24.4% | -53.1% |